Article

Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma

2021-04-26

Abstract excerpt

<h4>Abstract Figure</h4> Graphical abstract <h4>Individualized neoantigen vaccination against mammary carcinoma</h4> <h4>Background</h4> Harnessing the immune system to purposely recognize and destroy tumours represents a significant breakthrough in clinical oncology. Nonsynonymous mutations (neoantigenic peptides) were identified as powerful cancer targets. This knowledge can be exploited for further improveme...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bf351374-e998-5767-aef9-8004de59b247
DOI: 10.1101/2021.04.24.440778

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinomaDOI 10.1101/2021.04.24.440778Read

Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-VaccineSemantic proximity Read

Synthetic multiepitope neoantigen DNA vaccine for personalized cancer immunotherapy.Semantic proximity Read

VLP-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in miceSemantic proximity Read

Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapySemantic proximity Read

Comparison of Personal and Shared Frameshift Neoantigen Vaccines in a Mouse Mammary Cancer Model.Semantic proximity Read

IMPACT - Phase Ib Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell CarcinomaSemantic proximity Read

Identification and Targeting of Mutant Peptide Neoantigens in Cancer ImmunotherapySemantic proximity Read

In silico neoantigen screening and HLA multimer-based validation identify immunogenic neopeptide in multifocal lung adenocarcinoma.Semantic proximity Read

Neoantigen DNA vaccines are safe, feasible, and capable of inducing neoantigen-specific immune responses in patients with triple negative breast cancerSemantic proximity Read

Neoantigens: The Novel Precision Cancer ImmunotherapySemantic proximity Read

Personalized Neoantigen DNA Cancer Vaccines: Current Status and Future PerspectivesSemantic proximity Read

<i>Listeria monocytogenes</i> personalized cancer vaccines drive therapeutic immune responses to cancer derived neoantigensSemantic proximity Read